Fixed-dose versus patient-specific dosing of anticancer agents

It is generally accepted that body surface area (BSA)-based dosing results in significant inter-patient variability. Despite this, BSA-based dosing continues to form the mainstay of dosing strategies for chemotherapeutic agents. This article explores the alternatives available to BSA-based dosing.